Head and Neck Squamous Cell Carcinoma (HNSCC) Terminated Phase 2 Trials for DB01248 (Docetaxel)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00805012Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)Treatment